Core Viewpoint - Tianan Health (00383.HK) announced a renovation agreement for the second phase of Kunming Tongren Hospital, with a contract value of RMB 129.8 million, to be executed by Zhejiang Shunjie Construction [1] Group 1: Project Details - The renovation agreement includes the decoration and renovation of the Thyroid Center, Comprehensive Inpatient Building, and Rehabilitation Medicine Building [1] - Zhejiang Shunjie Construction has been the general contractor for the civil engineering of the second phase of Kunming Tongren Hospital, and the collaboration has been satisfactory [1] Group 2: Strategic Importance - The selection of the contractor for the renovation work aims to ensure a smooth continuation of the project following the completion of the civil engineering phase [1]

Core Viewpoint - Tianan Health (00383) announced a renovation agreement for the second phase of Kunming Tongren Hospital, with a total cost of RMB 130 million [1] Group 1: Agreement Details - The renovation agreement is between Kunming Tongren Hospital Co., Ltd. and Zhejiang ShunJie Construction Group Co., Ltd. [1] - The scope of the renovation includes the Thyroid Center, Comprehensive Inpatient Building, and Rehabilitation Medicine Building, covering a total construction area of approximately 48,357 square meters [1] Group 2: Management's Perspective - The board believes that the transaction under the renovation agreement is conducted on normal commercial terms [1] - The terms of the renovation agreement are considered fair and reasonable by the board [1] - Entering into the renovation agreement is deemed to be in the overall interest of the company and its shareholders [1]

Core Viewpoint - Tianan Health (00383.HK) announced a share buyback plan to repurchase 5,000 shares at a price of HKD 1 per share on November 12, 2025, totaling HKD 5,000 [1] Summary by Category - **Company Announcement** - Tianan Health plans to buy back 5,000 shares at a price of HKD 1 each [1] - The total amount for the buyback will be HKD 5,000 [1] - **Financial Implications** - The buyback indicates the company's strategy to enhance shareholder value [1] - The repurchase price reflects the company's current valuation and market conditions [1]

Core Viewpoint - Tianan Health (00383) announced a share buyback plan, intending to repurchase 5,000 shares at a total cost of HKD 5,000, with each share priced at HKD 1 [1] Summary by Category - **Company Actions** - The company will repurchase 5,000 shares, indicating a commitment to returning value to shareholders [1] - The buyback price is set at HKD 1 per share, reflecting the company's valuation strategy [1] - **Financial Implications** - The total expenditure for the buyback is HKD 5,000, which may impact the company's cash reserves [1]

智通财经APP讯，天安卓健(00383)发布公告，该公司于2025年11月12日斥资5000港元回购5000股股份， 每股回购价格为1港元。 ...

Group 1 - The company Tianan Health (00383) announced a share buyback plan, intending to repurchase 10,000 shares at a total cost of 9,900 HKD [1] - The buyback price per share is set at 0.99 HKD [1]

天安卓健(00383)发布公告，该公司于2025年11月11日斥资9900港元回购1万股股份，每股回购价格为 0.99港元。 ...

Core Viewpoint - Tianan Health (00383.HK) announced a share buyback of 10,000 shares at a cost of HKD 9,900 on November 11 [1] Group 1 - The company executed a buyback program, indicating a potential strategy to enhance shareholder value [1]

Core Insights - Zhongtian Anch has completed a new round of equity financing, with strategic investor Heizhima Intelligent Technology Co., Ltd. participating [1] - The company plans to develop a "traffic safety intelligent body" based on the Heizhima intelligent chip platform, integrating high-performance automotive-grade chips with multimodal large models [1] - Founded in 2013, Zhongtian Anch specializes in providing video remote information processing solutions for commercial vehicle fleets [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 天安中國投資有限公司 (「本公司」) 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 不適用 備註： 本公司並無法定股本及其股本中並無股份面值。 FF301 第 1 頁 共 10 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00028 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 1,466,069,491 | | 0 | | 1,466,069,491 | | 增加 / 減少 (-) | | | | | | | | | 本月底結存 | | | 1,4 ...